Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-20-035032

Director acquired 7,333 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Humphries William D. Director 2020-06-06 Option exercise +7,333 16,209 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Humphries William D. Director 2020-06-04 Grant or award · Option Grant (right to buy) +16,500 16,500 D: show line 2 in the form
Humphries William D. Director 2020-06-06 Option exercise · Restricted Stock Units −7,333 0 D: show line 3 in the form
Loading xslF345X03/doc4.xml…